New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2)
Riitta Sallinen(Folkhälsans Forskningscentrum), Bjarne Udd(Folkhälsans Forskningscentrum), Mario Sirito(Inserm), Nina Horelli‐Kuitunen, Shaozeng Zhang(The University of Texas MD Anderson Cancer Center), Kirsi Huoponen(University of Turku), G. Meola(IRCCS Policlinico San Donato), Hannu Kalimo(University of Turku), Hannu Haapasalo(Tampere University Hospital), Anna Vihola(University of Helsinki), Maija Wessman(University of Helsinki), Peter Hackman(Folkhälsans Forskningscentrum), Ralf Krahe(University of Helsinki), Linda L. Bachinski(Baylor College of Medicine)
Cited by 45
Related Papers
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin
|Proceedings of the National Academy of Sciences|2002|882
Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy
|New England Journal of Medicine|1998|759
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
|The Lancet Neurology|2012|487
Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin
|The American Journal of Human Genetics|2002|484
Genome-wide association analysis identifies susceptibility loci for migraine without aura
|Nature Genetics|2012|353